The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A preliminary trial of ascorbic acid as supplemental therapy for autism
Abstract
1. This study presents the results of a 30-week double-blind, placebo-controlled trial exploring the effectiveness of ascorbic acid (8g/70kg/day) as a supplemental pharmacological treatment for autistic children in residential treatment. 2. Residential school children (N = 18) were randomly assigned to either ascorbate-ascorbate-placebo treatment order group or ascorbate-placebo-ascorbate treatment order group. Each treatment phase lasted 10 weeks and behaviors were rated weekly using the Ritvo-Freeman scale. 3. Significant group by phase interactions were found for total scores and also sensory motor scores indicating a reduction in symptom severity associated with the ascorbic acid treatment. 4. These results were consistent with a hypothesized dopaminergic mechanism of action of ascorbic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other antioxidants have been studied in ASD including omega-3 fatty acids [71, 72] with mixed results”
From An Update on Psychopharmacological Treatment of Autism Spectrum Disorder (2022) · cites this paper as [72]
Citations
Cites
Psychopharmacology: The third generation of progress
O’Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,020
Seeman, P. M. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,888
Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms
Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.10.1195 · Cited by 323
Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five Years
Campbell, M., & SPENCER, E. K. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198805000-00001 · Cited by 182
A Scale for Rating Symptoms of Patients with the Syndrome of Autism in Real Life Settings
Freeman, B. J., RITVO, E. R., Yokota, A., & Ritvo, A. (1986) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60610-5 · Cited by 143
Tolbert, L. C., Thomas, T. N., Middaugh, L. D., & Zemp, J. W. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90091-2 · Cited by 96
Hadjiconstantinou, M., & Neff, N. H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90209-5 · Cited by 74
Rebec, G. V., Centore, J. M., White, L. K., & Alloway, K. D. (1985) · Science · doi:10.1126/science.4038426 · Cited by 71
Modulation of neostriatal activity by iontophoresis of ascorbic acid
Gardiner, T. W., Armstrong‐James, M., Caan, A. W., Wightman, R. M., & Rebec, G. V. (1985) · Brain Research · doi:10.1016/0006-8993(85)91207-7 · Cited by 52
Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions
Tolbert, L. C., Thomas, T. N., Middaugh, L. D., & Zemp, J. W. (1979) · Brain Research Bulletin · doi:10.1016/0361-9230(79)90056-x · Cited by 46
Inhibition of dopamine D-1 and D-2 binding sites in neuronal tissue by ascorbate
Kayaalp, S. O., Rubenstein, J. S., & Neff, N. H. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90018-6 · Cited by 43
Neuroleptic-related dyskinesias in autistic children: a prospective study.
Perry, R., Campbell, M., Wh, G., Small, A. M., Ml, D. T., MEISELAS, K. D., Rr, G., & Deutsch, S. I. (1985) · PubMed · Cited by 34
Megavitamin and Orthomolecular Therapy in Psychiatry
Robins, E. (1974) · American Journal of Public Health · doi:10.2105/ajph.64.4.410-a · Cited by 28
New technology in convulsive therapy: a challenge in training
Fink, M. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1195 · Cited by 23
Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations
Heikkila, R. E., Manzino, L., Cabbat, F. S., & Hanly, J. G. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90274-5 · Cited by 22
Pharmacology of [3H]apomorphine binding to bovine brain tissue
Arana, G. W., Baldessarini, R. J., & Harding, M. H. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90515-3 · Cited by 17
Schulz, D. W., Lewis, M. H., Petitto, J. M., & Mailman, R. B. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90035-4 · Cited by 14
Heikkila, R. E., & Cabbat, F. S. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90221-7 · Cited by 10
Nutrition and Developmental Disabilities
Raiten, D. J. (1987) · Springer eBooks · doi:10.1007/978-1-4899-1992-2_17 · Cited by 3
Research works printed but not linked: 3
- Tolbert, 1990, Comparison of the selectivity and specificity of ascorbic acid antagonism of dopaminergic agonist binding, Soc. Neurosci. Abstr., 16, 80
- Tolbert, 1989, Effects of ascorbic acid, isoascorbic acid, and gluroascorbic acid on the binding of the D2 agonist 3H-N-0437, Soc. Neurosci. Abstr., 15, 425
- Tolbert, 1979, Ascorbate effects conversion of tyrosine to dopamine in mouse brain, Trans. Amer. Soc. Neurochem., 10, 184
Cited by
Sorted by citations
Management of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 940
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Rossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.165 · Cited by 555
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00150 · Cited by 385
Metadata
- Authors
- Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L.
- Affiliations
- University of Alabama at Birmingham (US)
- ORCID
- Spollen, John
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 1993-09
- Volume
- 17
- Issue
- 5
- Pages
- 765-774
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2083633216
- Cited by
- 168
- References
- 19
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 4 · 2015: 12 · 2014: 15 · 2013: 5 · 2012: 11
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Keywords
- vitamin C, vitamin C supplementation, autism spectrum disorder, children with autism, residential treatment, sensory-motor behavior, dopaminergic mechanisms
- MeSH terms
- Adolescent, Adult, Ascorbic Acid, Autistic Disorder, Child, Double-Blind Method, Female, Humans, Male, Psychiatric Status Rating Scales
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
